Login / Signup

First, do no harm: a global perspective on diversity and inclusion in clinical trials.

Katharine WrightWillyanne DeCormier PloskyHayat R AhmedSarah A WhiteBarbara E Bierer
Published in: Nature reviews. Drug discovery (2024)
Keyphrases
  • clinical trial
  • phase ii
  • open label
  • phase iii
  • double blind
  • study protocol